Comprehensive Analysis of Clinicopathologic Factors Predictive of an Unfavorable Prognosis in Patients With Acinic Cell Carcinoma of the Parotid Gland
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. In subset of patients, acinic cell carcinoma (AcCC) exhibits aggressive features such as recurrence, distant metastasis, and mortality. This study aimed to investigate clinicopathologic factors influencing patients’ prognosis and to identify adverse features predictive of an unfavorable prognosis. Methods. Between January 2000 and December 2016, 59 patients with AcCC were enrolled in this study. Results. The patients’ 5-year overall survival rate was 93.3%, and their 5-year recurrence-free survival rate was 80.5%. During the study period, recurrence occurred in 10 patients. The mean time to recurrence after surgery was 26 months (range, 5–60 months). During the study period, three patients died from the disease. Univariate analysis showed that sex, surgical extent, extranodal extension, T classification, and TNM stage were significantly associated with disease recurrence. Multivariate analysis showed that, among the clinicopathologic factors included in the analysis, only TNM stage displayed a statistically significant correlation with disease recurrence. Conclusion. Surgical treatment alone yielded good results for AcCC, and additional treatment did not affect the recurrence-free survival rate or the overall survival rate, even when the resection margin was less than 1 mm. Other pathologic factors did not show prognostic significance for disease recurrence or death.
Abstract
Objectives. In subset of patients, acinic cell carcinoma (AcCC) exhibits aggressive features such as recurrence, distant metastasis, and mortality. This study aimed to investigate clinicopathologic factors influencing patients’ prognosis and to identify adverse features predictive of an unfavorable prognosis. Methods. Between January 2000 and December 2016, 59 patients with AcCC were enrolled in this study. Results. The patients’ 5-year overall survival rate was 93.3%, and their 5-year recurrence-free survival rate was 80.5%. During the study period, recurrence occurred in 10 patients. The mean time to recurrence after surgery was 26 months (range, 5–60 months). During the study period, three patients died from the disease. Univariate analysis showed that sex, surgical extent, extranodal extension, T classification, and TNM stage were significantly associated with disease recurrence. Multivariate analysis showed that, among the clinicopathologic factors included in the analysis, only TNM stage displayed a statistically significant correlation with disease recurrence. Conclusion. Surgical treatment alone yielded good results for AcCC, and additional treatment did not affect the recurrence-free survival rate or the overall survival rate, even when the resection margin was less than 1 mm. Other pathologic factors did not show prognostic significance for disease recurrence or death.
참고문헌 (12)
- Patel NR, "Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases", Laryngoscope, 124(1), pp.172~178 (2014)
- Gomez DR, "Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland", Cancer, 115(10), pp.2128~2137 (2009)
- Biron VL, "Factors influencing survival in acinic cell carcinoma: a retrospective survival analysis of 2061 patients", Head Neck, 37(6), pp.870~877 (2015)
- Cho JK, "Low-grade salivary gland cancers: treatment outcomes, extent of surgery and indications for postoperative adjuvant radiation therapy", Ann Surg Oncol, 23(13), pp.4368~4375 (2016)
- Richter SM, "Postoperative radiation therapy for small, low-", intermediate-grade parotid tumors with close and, Head Neck, pp.2012, 34(7)[DOI]
- Bakst RL, "Adjuvant radiation for salivary gland malignancies is associated with improved survival: a National Cancer Database analysis", Adv Radiat Oncol, 2(2), pp.159~166 (2017)
- Stodulski D, "Close surgical margin after conservative parotidectomy in early stage low-", intermediate-grade parotid carcinoma: outcome of watch and wait policy, 2017, pp.68, 1~4
- Hoffman HT, "National Cancer Data Base report on cancer of the head and neck:acinic cell carcinoma", Head Neck, 21(4), pp.297~309 (1999)
- Vander Poorten V, "Salivary acinic cell carcinoma: reappraisal and update", Eur Arch Otorhinolaryngol, 273(11), pp.3511~3531 (2016)
- Neskey DM, "Prognostic factors associated with decreased survival in patients with acinic cell carcinoma", JAMA Otolaryngol Head Neck Surg, 139(11), pp.1195~1202 (2013)
- Andreoli MT, "Radiotherapy in parotid acinic cell carcinoma: does it have an impact on survival?", Arch Otolaryngol Head Neck Surg, 138(5), pp.463~466 (2012)
- 차원재, "Clinical Analysis of Acinic Cell Carcinoma in Parotid Gland", Clinical and Experimental Otorhinolaryngology, 4(4), pp.188~192 (2011), 대한이비인후과학회